BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26160483)

  • 1. Cervical Cancer Screening for Patients on the Female-to-Male Spectrum: a Narrative Review and Guide for Clinicians.
    Potter J; Peitzmeier SM; Bernstein I; Reisner SL; Alizaga NM; Agénor M; Pardee DJ
    J Gen Intern Med; 2015 Dec; 30(12):1857-64. PubMed ID: 26160483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical Cancer Screening Preferences Among Trans-Masculine Individuals: Patient-Collected Human Papillomavirus Vaginal Swabs Versus Provider-Administered Pap Tests.
    McDowell M; Pardee DJ; Peitzmeier S; Reisner SL; Agénor M; Alizaga N; Bernstein I; Potter J
    LGBT Health; 2017 Aug; 4(4):252-259. PubMed ID: 28665783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Female-to-male patients have high prevalence of unsatisfactory Paps compared to non-transgender females: implications for cervical cancer screening.
    Peitzmeier SM; Reisner SL; Harigopal P; Potter J
    J Gen Intern Med; 2014 May; 29(5):778-84. PubMed ID: 24424775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Literature Review of Cervical Cancer Screening in Transgender Men.
    Gatos KC
    Nurs Womens Health; 2018 Feb; 22(1):52-62. PubMed ID: 29433700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding Transgender Men's Experiences with and Preferences for Cervical Cancer Screening: A Rapid Assessment Survey.
    Seay J; Ranck A; Weiss R; Salgado C; Fein L; Kobetz E
    LGBT Health; 2017 Aug; 4(4):304-309. PubMed ID: 28422558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical Papanicolaou tests in the female-to-male transgender population: should the adequacy criteria be revised in this population? An Institutional Experience.
    Plummer RM; Kelting S; Madan R; O'Neil M; Dennis K; Fan F
    J Am Soc Cytopathol; 2021; 10(3):255-260. PubMed ID: 33736951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Cervical Cancer Screen Results on Female-to-Male Transgender Patients With Female Patients.
    Davis K; Kwon R; Graham A; White M; Maleki Z; Rodriguez E
    Am J Clin Pathol; 2022 Apr; 157(4):540-545. PubMed ID: 34617991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients.
    Reisner SL; Deutsch MB; Peitzmeier SM; White Hughto JM; Cavanaugh TP; Pardee DJ; McLean SA; Panther LA; Gelman M; Mimiaga MJ; Potter JE
    PLoS One; 2018; 13(3):e0190172. PubMed ID: 29538411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomorphologic findings of cervical Pap smears from female-to-male transgender patients on testosterone therapy.
    Williams MPA; Kukkar V; Stemmer MN; Khurana KK
    Cancer Cytopathol; 2020 Jul; 128(7):491-498. PubMed ID: 32125771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pap test use is lower among female-to-male patients than non-transgender women.
    Peitzmeier SM; Khullar K; Reisner SL; Potter J
    Am J Prev Med; 2014 Dec; 47(6):808-12. PubMed ID: 25455121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of satisfaction with three different cervical cancer screening modalities: clinician-collected Pap test vs. HPV test by self-sampling vs. HPV test by urine sampling.
    Shin HY; Lee B; Hwang SH; Lee DO; Sung NY; Park JY; Jun JK
    J Gynecol Oncol; 2019 Sep; 30(5):e76. PubMed ID: 31328458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "It Can Promote an Existential Crisis": Factors Influencing Pap Test Acceptability and Utilization Among Transmasculine Individuals.
    Peitzmeier SM; Agénor M; Bernstein IM; McDowell M; Alizaga NM; Reisner SL; Pardee DJ; Potter J
    Qual Health Res; 2017 Dec; 27(14):2138-2149. PubMed ID: 28836483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Acceptability and Preference of Vaginal Self-sampling for Human Papillomavirus (HPV) Testing among a Multi-ethnic Asian Female Population.
    Khoo SP; Lim WT; Rajasuriar R; Nasir NH; Gravitt P; Woo YL
    Cancer Prev Res (Phila); 2021 Jan; 14(1):105-112. PubMed ID: 32917643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends Over Time in Pap and Pap-HPV Cotesting for Cervical Cancer Screening.
    MacLaughlin KL; Jacobson RM; Radecki Breitkopf C; Wilson PM; Jacobson DJ; Fan C; St Sauver JL; Rutten LJF
    J Womens Health (Larchmt); 2019 Feb; 28(2):244-249. PubMed ID: 30614380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Participation in Cervical Screening by Self-collection, Pap, or a Choice of Either in Brazil.
    Castle PE; Silva VRS; Consolaro MEL; Kienen N; Bittencourt L; Pelloso SM; Partridge EE; Pierz A; Dartibale CB; Uchimura NS; Scarinci IC
    Cancer Prev Res (Phila); 2019 Mar; 12(3):159-170. PubMed ID: 30651294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical cancer screening with clinic-based Pap test versus home HPV test among Somali immigrant women in Minnesota: a pilot randomized controlled trial.
    Sewali B; Okuyemi KS; Askhir A; Belinson J; Vogel RI; Joseph A; Ghebre RG
    Cancer Med; 2015 Apr; 4(4):620-31. PubMed ID: 25653188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muslim immigrant women's views on cervical cancer screening and HPV self-sampling in Ontario, Canada.
    Vahabi M; Lofters A
    BMC Public Health; 2016 Aug; 16(1):868. PubMed ID: 27557928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are Health Care Professionals Prepared to Implement Human Papillomavirus Testing? A Review of Psychosocial Determinants of Human Papillomavirus Test Acceptability in Primary Cervical Cancer Screening.
    Tatar O; Wade K; McBride E; Thompson E; Head KJ; Perez S; Shapiro GK; Waller J; Zimet G; Rosberger Z
    J Womens Health (Larchmt); 2020 Mar; 29(3):390-405. PubMed ID: 31479381
    [No Abstract]   [Full Text] [Related]  

  • 19. Age at last screening and remaining lifetime risk of cervical cancer in older, unvaccinated, HPV-negative women: a modelling study.
    Malagón T; Kulasingam S; Mayrand MH; Ogilvie G; Smith L; Bouchard C; Gotlieb W; Franco EL
    Lancet Oncol; 2018 Dec; 19(12):1569-1578. PubMed ID: 30392810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical Cancer Screening with Human Papillomavirus Self-Sampling Among Transgender Men in El Salvador.
    Maza M; Meléndez M; Herrera A; Hernández X; Rodríguez B; Soler M; Alfaro K; Masch R; Conzuelo-Rodríguez G; Obedin-Maliver J; Cremer M
    LGBT Health; 2020; 7(4):174-181. PubMed ID: 32407149
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.